At Mallinckrodt, we believe our corporate responsibility goes beyond the millions of people whose lives we touch each and every day.
We’ve integrated responsible business practices into everything we do. From our broad efforts to encourage responsible and safe use of opioid pain medications to manufacturing high-quality products for patients, our commitment to building a better tomorrow is stronger than ever.
Explore how Mallinckrodt is committed to conducting responsible business for a healthier world.
Pledge on Drug Pricing and Innovation
Mallinckrodt’s Pledge to America: Create the best possible healthcare at the lowest possible cost for the greatest number of people.
Interactions with Healthcare Professionals
Mallinckrodt Pharmaceuticals has a long-standing policy of abiding by industry ethical codes on its interaction with healthcare professionals.
Policy on Expanded Access Program for Investigational Drugs
It is Mallinckrodt’s policy to be able to provide appropriate and ethical access to its investigational medicines to patients under certain defined circumstances prior to marketing authorization, but outside of the planned clinical research program. Such Expanded Access, or Compassionate Use, Programs are for exceptional circumstances only.
Mallinckrodt Pharmaceuticals is dedicated to providing safe and effective medications for the treatment of patients with pain and is equally committed to working with policymakers, law enforcement, patient groups and other stakeholders to address the complex issues of opioid diversion and abuse.
From our global and U.S. headquarters to operating sites around the world, Mallinckrodt demonstrates its commitment to philanthropy by giving back to the communities that have helped us grow for 150 years.
Sustainability has always been an important part of our heritage, and it will continue to be as we evolve and progress toward the future.